
Solstice Capital
Description
Solstice Capital is a seasoned early-stage venture capital firm with a long-standing presence in the investment landscape, having been founded in 1997. The firm is dedicated to identifying and supporting promising seed and early-stage companies, aligning with its stated goal of generating superior venture capital returns for its limited partners. While the provided information specified "Salem" as its location, the firm widely recognized for its venture capital activities matching this description operates out of Tucson, Arizona.
The firm's investment thesis centers on disruptive technologies and innovative business models across a range of high-growth sectors. Solstice Capital primarily targets opportunities within software, internet, mobile, e-commerce, fintech, healthcare IT, and SaaS. Geographically, while it has a strong presence and focus on the Southwest United States, including Arizona, California, Texas, and Colorado, its investment reach extends to companies across the nation.
Solstice Capital typically deploys initial checks ranging from $500,000 to $3 million, making it a key partner for companies in their formative stages. The firm has demonstrated consistent fundraising success, notably closing its Fund V in 2018 with $100 million in committed capital, underscoring its continued capacity for investment. With a track record spanning over two decades, Solstice Capital has made more than 100 investments and facilitated over 20 exits, showcasing its ability to identify and nurture successful ventures. The firm prides itself on not just providing capital, but also offering strategic guidance and operational support to its portfolio companies, leveraging its extensive network and experience to help founders scale their businesses.
Investor Profile
Solstice Capital has backed more than 44 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 5% of its total and boasts 17 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series C, Series Unknown rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biotechnology, Software, Health Care.
- Typical check size: $500K – $3M.
Stage Focus
- Series B (32%)
- Series C (23%)
- Series Unknown (20%)
- Series A (20%)
- Series D (5%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Software
- Health Care
- Manufacturing
- Medical
- Electronics
- Therapeutics
- Genetics
- Health Diagnostics
- Life Science
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.